Search results for "Atrial"

showing 10 items of 564 documents

The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study

2020

Abstract Background High blood lipid levels are known risk factors for atherosclerotic cardiovascular events, but associations between lipid levels and atrial fibrillation (AF) are unclear. Some previous studies have suggested an inverse association between lipid levels and AF referred to as the “cholesterol paradox”. Purpose To examine the prevalence of AF by differing lipid levels in a large population-based study of almost 14,000 adults in Poland. Methods The LIPIDOGRAM 2015 study is a cross-sectional study of adults aged 18 years and older recruited in Poland in 2015/2016 by 438 family physicians. Poisson regression models with robust variance were used to estimate prevalence ratios (PR…

Cardiovascular eventmedicine.medical_specialtyCholesterolbusiness.industryCardiac arrhythmiaAtrial fibrillationLipid Measurementmedicine.diseaseDrug usagechemistry.chemical_compoundWaist–hip ratiochemistryInternal medicineCardiologymedicineLDL Cholesterol Lipoproteinslipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Atrial natriuretic factor, but not oxytocin, is present in atherosclerotic plaques of human common carotid arteries

2010

We performed a study on 25 common carotid arteries (CCA) affected by atherosclerotic plaques, comparing them to 25 normal CCA. We researched the presence and localisation of atrial natriuretic factor (ANF) and oxytocin (OX) by immunohistochemistry. We found ANF abundantly expressed in plaques, mainly localising in intima and subintima layers; by contrast normal vessels were scarcely positive or negative; finally, OX resulted negative or weakly positive in both atherosclerotic and normal vessels. Our results show for the first time ANF presence in atherosclerotic plaques of CCA and are in agreement with other studies, mainly performed in vitro, that hypothesise the involvement of this molecu…

Carotid Artery DiseasesMaleNatriuretic peptide Atherosclerosis InflammationSettore BIO/16 - Anatomia UmanaAnti-Inflammatory AgentsMiddle AgedOxytocinImmunohistochemistryDrug DesignHumansCarotid StenosisFemaleTunica IntimaVasculitis Central Nervous SystemAtrial Natriuretic FactorBiomarkersAged
researchProduct

Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.

2015

OBJECTIVE: Carotid intima-media thickness (cIMT) is a surrogate marker of subclinical atherosclerosis and it is able to predict both coronary and cerebral vascular events. No data exist on the association between cIMT and non valvular atrial fibrillation (NVAF) type. We conduct this study with the aim to analyze the association between abnormal cIMT and NVAF type. METHODS: A cross-sectional study of the "Atrial fibrillation Registry for Ankle-brachial index Prevalence Assessment-Collaborative Italian Study (ARAPACIS)" has been performed. Among 2027 patients enrolled in the ARAPACIS, 673 patients, who underwent carotid ultrasound examination to assess cIMT, were included in the study. RESULT…

Carotid Artery DiseasesMaleRegistrieSettore MED/09 - Medicina Internagenetic structuresCross-sectional studycarotid intima-media thickness; non valvular atrial fibrillation; ARAPACIScarotid atherosclerosisPredictive Value of TestComorbiditySubclinical atherosclerosiintima-media-thicknessCarotid intima-media thickneRisk FactorsAtrial Fibrillation80 and overPrevalencenonvalvular atrial fibrillation; intima-media-thickness; carotid atherosclerosisRegistriesCarotid intima-media thicknessStrokeAged 80 and overCarotid intima-media thickness; Paroxysmal non valvular atrial fibrillation; Persistent/permanent non valvular atrial fibrillation; Subclinical atherosclerosis; Aged; Aged 80 and over; Ankle Brachial Index; Asymptomatic Diseases; Atrial Fibrillation; Carotid Artery Diseases; Carotid Artery Common; Chi-Square Distribution; Comorbidity; Cross-Sectional Studies; Female; Humans; Italy; Linear Models; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prevalence; Registries; Risk Factors; Carotid Intima-Media ThicknessMedicine (all)Atrial fibrillationMiddle AgedCommonItalyPredictive value of testsnon valvular atrial fibrillationCardiologycardiovascular systemLinear ModelFemaleCardiology and Cardiovascular MedicineHumanmedicine.medical_specialtyLogistic ModelCarotid Artery CommonPersistent/permanent non valvular atrial fibrillationparoxysmal non valvular atrial fibrillation; persistent/permanent non valvular atrial fibrillation; subclinical atherosclerosis; carotid intima-media thicknessPredictive Value of TestsParoxysmal non valvular atrial fibrillationInternal medicinemedicineHumansAnkle Brachial Indexcardiovascular diseasesSubclinical atherosclerosisCarotid intima-media thickness; Paroxysmal non valvular atrial fibrillation; Persistent/permanent non valvular atrial fibrillation; Subclinical atherosclerosisAgedCross-Sectional StudieAsymptomatic DiseaseCarotid Artery DiseaseChi-Square Distributionbusiness.industrySurrogate endpointRisk Factornonvalvular atrial fibrillationmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareComorbidityParoxysmal Non Valvular Atrial Fibrillation Persistent/Permanent Non Valvular Atrial Fibrillation Subclinical Atherosclerosis Carotid Intima-Media ThicknessCross-Sectional StudiesLogistic ModelsIntima-media thicknessAsymptomatic DiseasesLinear ModelsARAPACISCarotid ArterybusinessChi-squared distribution
researchProduct

Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy

2019

AbstractThe most common causes of ischaemic stroke are represented by carotid artery atherosclerotic disease (CAAD) and atrial fibrillation. While oral anticoagulants substantially reduce the incidence of thromboembolic stroke (< 1%/year), the rate of ischaemic stroke and other cardiovascular disease events in patients with CAAD remains high, ranging from 8.4 to 18.1 events per 100 patient-years. Similar to any other atherosclerotic disease, anti-thrombotic therapies are proposed for CAAD to reduce stroke and other cardiovascular events. The 2017 European Society of Cardiology (ESC)/European Society for Vascular Surgery (ESVS) guidelines recommend for patients with asymptomatic CAAD ≥60%…

Carotid Artery DiseasesMaleRisk0301 basic medicinemedicine.medical_specialtyCardiologyHemorrhageThromboembolic stroke030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineRivaroxabanCarotid artery diseaseInternal medicineIschaemic strokeMyocardial RevascularizationmedicineHumansAgedAspirinbusiness.industryIncidence (epidemiology)Atherosclerotic diseaseAnticoagulantsAtrial fibrillationHematologyMiddle AgedAtherosclerosismedicine.diseaseClopidogrelReview articleCarotid Arteries030104 developmental biology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCardiovascular Diseasesanti-platelet; anti-thrombotic therapy; anticoagulant; aspirin; carotid artery disease; rivaroxabanCardiologyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessPlatelet Aggregation InhibitorsThrombosis and Haemostasis
researchProduct

Electrocardiographic abnormalities, preclinical carotid atherosclerosis and cardiovascular risk in an apparently healthy real-world population. Data …

2021

Background: Cardiovascular diseases (CVDs) represent important causes of morbidity and mortality. Our study aimed to evaluate cardiovascular risk using the EuroSCORE, ECG and carotid ultrasound for prevention purpose in a population of companions aged 50-70 years, asymptomatic and without CVD. Methods: History of CVD, risk factors (RF), ECG and carotid ultrasound were evaluated. Intima-media thickness (IMT) was defined as wall thickness >0.9 mm, while focal thickening ≥1.5 mm protruding into the lumen as asymptomatic carotid plaque (ACP). Results: Totally, 1860 subjects were screened. 393 (21.1%) had no RF, 780 (42%) hypertension, 571 (30.7%) hypercholesterolemia, 557 (29.9%) diabetes, 4…

Carotid Artery Diseasesmedicine.medical_specialtyPopulationInfarctionCarotid Intima-Media ThicknessAsymptomaticRisk FactorsInternal medicineDiabetes mellitusmedicineHumanscardiovascular diseaseseducationSicilyStrokeAtherosclerosis Carotid intima-media thickness Heart disease risk factors Prevention and control Strokeeducation.field_of_studyMaltabusiness.industryAtrial fibrillationEuroSCOREmedicine.diseaseCardiovascular DiseasesHeart Disease Risk FactorsCardiologymedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessInternational Angiology
researchProduct

Analyse et détection des électrogrammes complexes fractionnés en vue de soigner la fibrillation auriculaire à l'aide de techniques d'ablation par rad…

2013

This manuscript presents research on the analysis and the detection of Complex Fractionated Atrial Electrograms (CFAE). In the first part, following a presentation over Atrial Fibrillation (AF) mechanisms and bioelectrical signals, the most commonly used tools for analyzing CFAE are presented. Linear tools are initially applied to signals from AF ablation procedures, then nonlinear tools are shown and integrated intoa CFAE detection algorithm. This one is based on the quantification of electrogram recurrence properties. In the second part, the cell and cardiac muscle tissue are described and simulated using mathematical models. Models such as FitzHugh Nagumo, Aliev Panfilov and Courtemanche…

Cathéter[SPI.OTHER]Engineering Sciences [physics]/OtherRadiofrequency Ablation[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology[ SPI.OTHER ] Engineering Sciences [physics]/Other[SPI.OTHER] Engineering Sciences [physics]/OtherDétectionAbla-tion par Radiofréquence[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyAtrial FibrillationComplex Fractionated Atrial Electrogram (CFAE)Electrogrammes Auriculaires Complexes FractionnésFibrillation Auriculaire[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

ANP (Atrial Natriuretic Peptide) presence in the heart of a tunicate, Ciona intestinalis.

2010

Atrial natriuretic peptide was found in the heart of vertebrates, we studied the ANP presence in the heart of Ciona intestinalis. This is animal is very important because of the its evolutionary position between invertebrates and vertebrates. ANP presence was only revealed in myoepithelial cells of the myocardium. Results suggest the hypothesis that ANP is present not only in the vertebrates but also in the invertebrates and in Ciona heart ANP might play a similar role like in the heart of vertebrates.

Cell physiologymedicine.medical_specialtyHistologyPathology and Forensic MedicineAtrial natriuretic peptideInternal medicinebiology.animalANP heart tunicates Ciona intestinalismedicineAnimalsCiona intestinalislcsh:QH573-671ANP - Atrial natriuretic peptidebiologylcsh:CytologyMyocardiumMyoepithelial cellVertebrateGeneral Medicinebiology.organism_classificationCiona intestinalisTunicateCionaEndocrinologyembryonic structurescardiovascular systemAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologyFolia Histochemica et Cytobiologica
researchProduct

Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ven…

2012

Background— Catecholaminergic polymorphic ventricular tachycardia is characterized by stress-triggered syncope and sudden death. Patients with catecholaminergic polymorphic ventricular tachycardia manifest sinoatrial node (SAN) dysfunction, the mechanisms of which remain unexplored. Methods and Results— We investigated SAN [Ca 2+ ] i handling in mice carrying the catecholaminergic polymorphic ventricular tachycardia–linked mutation of ryanodine receptor (RyR2 R4496C ) and their wild-type (WT) littermates. In vivo telemetric recordings showed impaired SAN automaticity in RyR2 R4496C mice after isoproterenol injection, analogous to what was observed in catecholaminergic polymorphic ventricul…

ChronotropicTachycardiaMalePatch-Clamp TechniquesAction Potentials030204 cardiovascular system & hematologyVentricular tachycardiaMice0302 clinical medicineSinoatrial NodeCatecholaminergic0303 health sciencesRyanodine receptorAdrenergic beta-AgonistsMiddle AgedSarcoplasmic Reticulummedicine.anatomical_structurecardiovascular systemCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyIn Vitro TechniquesCatecholaminergic polymorphic ventricular tachycardiaSudden deathArticle03 medical and health sciencesPhysiology (medical)Internal medicinemedicineAnimalsHumansCalcium SignalingExercise030304 developmental biologyAgedbusiness.industrySinoatrial nodeIsoproterenolRyanodine Receptor Calcium Release Channelmedicine.diseaseMice Mutant StrainsMice Inbred C57BLDisease Models AnimalEndocrinologyMutationTachycardia VentricularCalciumbusinessCirculation
researchProduct

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction

2018

Aims The mechanisms of exercise intolerance in heart failure with preserved ejection fraction (HFpEF) are not yet elucidated. Chronotropic incompetence has emerged as a potential mechanism. We aimed to evaluate whether heart rate (HR) response to exercise is associated to functional capacity in patients with symptomatic HFpEF. Methods and results We prospectively studied 74 HFpEF patients [35.1% New York Heart Association Class III, 53% female, age (mean ± standard deviation) 72.5 ± 9.1 years, and 59.5% atrial fibrillation]. Functional performance was assessed by peak oxygen consumption (peak VO2 ). The mean (standard deviation) peak VO2 was 10 ± 2.8 mL/min/kg. The following chronotropic pa…

Chronotropicmedicine.medical_specialtybusiness.industryAtrial fibrillationExercise intolerance030204 cardiovascular system & hematologymedicine.diseaseConfidence interval03 medical and health sciences0302 clinical medicineInternal medicineHeart failureHeart ratemedicineCardiologyIn patient030212 general & internal medicinemedicine.symptomCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionESC Heart Failure
researchProduct

A fifth class of antiarrhythmic action?

1981

Class (set theory)Action (philosophy)ChemistryMathematics educationHumansCalciumGeneral MedicineAnti-Arrhythmia AgentsClonidineSinoatrial NodeLancet (London, England)
researchProduct